Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
7 pending office actions • 3 clients • 6 examiners • 6 art units • 0 of 7 (0%) have an AI response strategy ready
Antoinette G Giugliano PC focuses on the Biotechnology & Pharmaceuticals technology area, where it has handled 320 career applications. This focused practice size indicates specialized expertise in life sciences patent prosecution. The firm currently has 5 pending office actions under its management, showing a dedicated focus on its current docket.
The firm maintains a resolved allowance rate pct of 82.22, showing a strong ability to secure patent grants in a complex field. Prosecution efficiency is reflected in the 2.72 avg office actions per allowance. This figure suggests that the firm typically reaches an allowance in several substantive interactions with the examiner, which is efficient for biotechnology matters.
For clients in the Biotechnology & Pharmaceuticals sector, the 82.22 resolved allowance rate pct offers a solid degree of confidence. The 2.72 avg office actions per allowance indicates a prosecution process that is both effective and relatively streamlined. With 320 career applications and 5 pending office actions, the firm demonstrates a consistent track record of success in the life sciences.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (29%) |
| §102 only | 1 (14%) |
| §112 only | 1 (14%) |
| Double-patenting only | 1 (14%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOSAR, AARON J | 2 | 71.2% | +29.9% |
| LAU, JASON | 1 | 53.7% | +15.6% |
| VIJAYARAGHAVAN, JAGAMYA NMN | 1 | 62.5% | +49.3% |
| PILCHER, JONATHAN L | 1 | 64.3% | +44.0% |
| MARTIN, PAUL C | 1 | 41.8% | +21.6% |
| GUINO-O UZZLE, MARITES A | 1 | 68.9% | +16.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17779213 | METHODS FOR PRODUCING CEMENT COMPRISING A SUPPLEMENTARY CEMENTITIOUS MATERIAL, AND CEMENT OBTAINABLE THEREBY | GUINO-O UZZLE, MARITES A | 120d overdue |
| 18467089 | Blood Plasma Product | VIJAYARAGHAVAN, JAGAMYA NMN | 26d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17779213 | METHODS FOR PRODUCING CEMENT COMPRISING A SUPPLEMENTARY CEMENTITIOUS MATERIAL, AND CEMENT OBTAINABLE THEREBY | GUINO-O UZZLE, MARITES A | 120d overdue |
| 18791873 | Alignment of A Disposable For A Spray Drying Plasma System | LAU, JASON | 43d overdue |
| 17945126 | Pretreatment Of Plasma For Spray Drying And Storage | MARTIN, PAUL C | 32d overdue |
| 18467074 | Pretreatment Of Plasma For Spray Drying And Storage | PILCHER, JONATHAN L | 16d |
| 18467089 | Blood Plasma Product | VIJAYARAGHAVAN, JAGAMYA NMN | 26d |
| 18745283 | Formulations And Methods For Contemporaneous Stabilization Of Active Proteins During Spray Drying And Storage | KOSAR, AARON J | — |
| 18406981 | Process For Purification of Chemical Components From Plant Matter | KOSAR, AARON J | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Velico Medical, Inc. | 5 |
| Kb Crash Creations LLC | 1 |
| Cemgreen APS | 1 |
| Art Unit | Apps |
|---|---|
| 3762 | 1 |
| 3653 | 1 |
| 1633 | 1 |
| 1772 | 1 |
| 1653 | 1 |
| 1731 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18791873 | Alignment of A Disposable For A Spray Drying Plasma System | Velico Medical, Inc. | LAU, JASON | 3762 | §102Other | Final Rejection | 43d overdue | Pending | Aug 01, 2024 |
| 18745283 | Formulations And Methods For Contemporaneous Stabilization Of Active Proteins During Spray Drying And Storage | Velico Medical, Inc. | KOSAR, AARON J | DP | Non-Final OA | — | Pending | Jun 17, 2024 | |
| 18406981 | Process For Purification of Chemical Components From Plant Matter | Kb Crash Creations LLC | KOSAR, AARON J | 3653 | §112 | Non-Final OA | — | Pending | Jan 08, 2024 |
| 18467089 | Blood Plasma Product | Velico Medical, Inc. | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §103§112Other | Final Rejection | 26d | Pending | Sep 14, 2023 |
| 18467074 | Pretreatment Of Plasma For Spray Drying And Storage | Velico Medical, Inc. | PILCHER, JONATHAN L | 1772 | §103 | Final Rejection | 16d | Pending | Sep 14, 2023 |
| 17945126 | Pretreatment Of Plasma For Spray Drying And Storage | Velico Medical, Inc. | MARTIN, PAUL C | 1653 | §103 | Final Rejection | 32d overdue | Pending | Sep 15, 2022 |
| 17779213 | METHODS FOR PRODUCING CEMENT COMPRISING A SUPPLEMENTARY CEMENTITIOUS MATERIAL, AND CEMENT OBTAINABLE THEREBY | Cemgreen Aps | GUINO-O UZZLE, MARITES A | 1731 | §103§112 | Non-Final OA | 120d overdue | Pending | May 24, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial